Johnson & Johnson (JNJ) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY Guidance

Johnson & Johnson (NYSE: JNJ) reported Q1 EPS of $2.70, $0.02 better than the analyst estimate of $2.68. Revenue for the quarter came in at $24.1 billion versus the consensus estimate of $23.61 billion.

GUIDANCE:

Johnson & Johnson sees FY2026 EPS of $11.55, versus the consensus of $11.55. Johnson & Johnson sees FY2026 revenue of $100.8 billion, versus the consensus of $100.65 billion.

For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.

You May Also Be Interested In

• Crude Inventory Fell 3.8 Million Barrels Last Week, Says EIA
• Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity
• Bending Spoons (BSP) indicating to open at $32, IPO priced at $29